Insider insights on the strategy behind Agilent and BioTek’s combined live-cell analysis portfolio
Agilent Technologies’ acquisition of BioTek Instruments will strengthen its leadership position in the growing cell analysis segment, says Senior Vice President, Jason Thaysen